Mumbai, India

Meenakshi Sivakumar

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Piramal Enterprises Limited, Piramal Life Sciences Limited, Council of Scientific and Industrial Research. Active years: 2011-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meenakshi Sivakumar. Retrieved from https://idiyas.com/inventor/meenakshi-sivakumar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0


 

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Maharastra, IN (2011)
  • Maharashtra, IN (2013)
  • Mumbai, IN (2011 - 2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Meenakshi Sivakumar: A Trailblazer in Pharmaceutical Innovations**

Introduction

Meenakshi Sivakumar is an accomplished inventor based in Mumbai, India, renowned for her significant contributions to the field of pharmaceutical chemistry. With a robust portfolio of five patents, she has made remarkable strides in developing compounds that address critical medical issues, particularly in oncology.

Latest Patents

Among her latest innovations, Meenakshi has developed a series of styrenyl 1,2,4-oxadiazole compounds. This invention pertains to oxadiazole compounds in all their stereoisomeric and tautomeric forms, as well as their pharmaceutically acceptable salts, solvates, prodrugs, and polymorphs. These compounds are particularly valuable in treating cancer, specifically chronic myeloid leukemia (CML). The invention includes processes for manufacturing these compounds and pharmaceutical compositions containing them, outlining a method for treating cancer by administering a therapeutically effective amount of the compounds to affected mammals.

Additionally, Meenakshi has patented enantiomerically pure compounds aimed at treating proliferative disorders. This invention details the (+)-trans enantiomer of a specific compound, including enantiomerically pure intermediates and processes for their preparation. The compounds have significant therapeutic potential for treating diseases related to the inhibition of cyclin-dependent kinase, emphasizing their importance in cancer treatment.

Career Highlights

Meenakshi's career is accentuated by her tenure at reputable organizations such as Piramal Enterprises Limited and Piramal Life Sciences Limited. During her time at these companies, she engaged in cutting-edge research, contributing to the development of innovative pharmaceutical solutions and furthering her expertise in the field.

Collaborations

Throughout her career, Meenakshi has collaborated with esteemed colleagues, including Kalpana Sanjay Joshi and Malcolm Mascarenhas. These partnerships have bolstered her research endeavors, allowing for the fusion of ideas and expertise that enhance the innovative processes in which she participates.

Conclusion

In conclusion, Meenakshi Sivakumar stands out as a significant figure in the pharmaceutical sector, with her inventive spirit driving advancements in cancer treatment through her patented compounds. Her career trajectory exemplifies the fusion of scientific inquiry and practical application, marking her as a vital contributor to contemporary medical innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…